2022
DOI: 10.1016/j.wneu.2021.11.119
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of Short-Term versus Long-Term Readmission-Free Survival After Metastatic Spine Tumor Surgery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 45 publications
0
4
0
Order By: Relevance
“…36 Moreover, in a retrospective single-institution study of 350 adult patients undergoing surgery for vertebral column tumors, Ehresman et al found that higher mFI-5-de ned frailty risk was a signi cant predictor of non-routine discharge. 37 Regarding HFRS-de ned frailty risk, in the retrospective NIS database study of 11,480 patients undergoing surgery for metastatic spinal column tumors, Elsamadicy et al showed that intermediate (HFRS [5][6][7][8][9][10][11][12][13][14][15] and high (HFRS > 15) frailty risk each independently predicted extended LOS and non-routine discharge. 7 Similarly, in the retrospective NIS database study of 5,955 patients undergoing surgery for primary spinal or intradural cord tumors, Elsamadicy et al observed that increased HFRS-de ned frailty risk was signi cantly associated with extended LOS and non-routine discharge.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…36 Moreover, in a retrospective single-institution study of 350 adult patients undergoing surgery for vertebral column tumors, Ehresman et al found that higher mFI-5-de ned frailty risk was a signi cant predictor of non-routine discharge. 37 Regarding HFRS-de ned frailty risk, in the retrospective NIS database study of 11,480 patients undergoing surgery for metastatic spinal column tumors, Elsamadicy et al showed that intermediate (HFRS [5][6][7][8][9][10][11][12][13][14][15] and high (HFRS > 15) frailty risk each independently predicted extended LOS and non-routine discharge. 7 Similarly, in the retrospective NIS database study of 5,955 patients undergoing surgery for primary spinal or intradural cord tumors, Elsamadicy et al observed that increased HFRS-de ned frailty risk was signi cantly associated with extended LOS and non-routine discharge.…”
Section: Discussionmentioning
confidence: 99%
“…In the retrospective NRD database study of 1,974 patients with increased risk of frailty and 1,975 low-frailty-risk controls undergoing surgery for spinal metastases from 2016 to 2017, Bakhsheshian et al observed that patients with greater frailty risk had higher mean costs of admission and that increased risk of frailty was an independent predictor of increased costs. 36 Conversely, in the retrospective NIS database study of 11,480 patients undergoing surgery for metastatic spinal column tumors, Elsamadicy et al found that while mean total costs increased signi cantly along with increasing HFRS, intermediate (HFRS [5][6][7][8][9][10][11][12][13][14][15] and high (HFRS > 15) HFRS did not predict increased costs on multivariate analysis. 7 Similarly, in the retrospective NIS database study of 5,955 patients undergoing surgery for primary spinal or intradural cord tumors, Elsamadicy et al demonstrated that while patients with increased HFRS had higher mean costs, increased frailty risk did not signi cantly associate with increased costs on multivariate analysis.…”
Section: Discussionmentioning
confidence: 99%
“…While readmission likely does not directly impact patient's survival, it may be a downstream sign of functional decline and a proxy for postoperative morbidity. 31 Most studies exploring the impact of readmission on OS in cancer patients undergoing surgery draw from nonspine specialties, such as colorectal cancer, 32 esophageal cancer, 33 and ovarian cancer. 34 Readmission-free survival is a novel clinical metric that was developed by Kumar et al 35 in 266 patients undergoing spinal metastasis surgery, further highlighting the importance of avoiding readmissions to improve survival.…”
Section: Discussionmentioning
confidence: 99%
“…Unplanned readmission was associated with decreased OS. While readmission likely does not directly impact patient’s survival, it may be a downstream sign of functional decline and a proxy for postoperative morbidity 31. Most studies exploring the impact of readmission on OS in cancer patients undergoing surgery draw from nonspine specialties, such as colorectal cancer,32 esophageal cancer,33 and ovarian cancer 34.…”
Section: Discussionmentioning
confidence: 99%